Abstract
Ethnic differences in non-communicable disease risk have been described between individuals of South Asian and European ethnicity that are only partially explained by genetics and other known risk factors. DNA methylation is one underexplored mechanism that may explain differences in disease risk. Currently there is little knowledge of how DNA methylation varies between South Asian and European ethnicities.
This study characterised differences in blood DNA methylation between individuals of self-reported European and South Asian ethnicity from two UK-based cohorts; Southall and Brent Revisited (SABRE) and Born in Bradford (BiB). DNA methylation differences between ethnicities were widespread throughout the genome (n=16,433 CpG sites, 3.4% sites tested). Specifically, 76% of associations were attributable to ethnic differences in cell composition with fewer effects attributable to smoking and genetic variation. Ethnicity associated CpG sites were enriched for EWAS Catalog phenotypes including metabolites. This work highlights the need to consider ethnic diversity in epigenetic research.
Competing Interest Statement
DAL has received support from Roche Diagnostics and Medtronic Ltd during the last 10-years for research unrelated to this study. NC serves on and receives remuneration for data monitoring and safety committees of trials sponsored by AstraZeneca. Other authors declare no conflict of interest.
Funding Statement
The SABRE study was funded at baseline by the Medical Research Council, Diabetes UK, and the British Heart Foundation. At follow up the study was funded by the Wellcome Trust and the British Heart Foundation. Methylation analysis in the SABRE cohort was supported by a Wellcome Trust Enhancement grant 082464/Z/07/C. Genotyping analysis in the SABRE cohort was supported by the British Heart Foundation (CS/13/1/30327) Born in Bradford is only possible because of the enthusiasm and commitment of the Children and Parents in BiB. We are grateful to all the participants, teachers, school staff, health professionals and researchers who have made Born in Bradford happen. BiB receives core infrastructure funding from the Wellcome Trust (WT101597MA), a joint grant from the UK Medical Research Council (MRC) and Economic and Social Science Research Council (ESRC) (MR/N024397/1), the British Heart Foundation (CS/16/4/32482) and the National Institute for Health Research (NIHR) under its Applied Research Collaboration (ARC) for Yorkshire and Humber and the Clinical Research Network (CRN). DNA methylation data was funded by the UK Medical Research Council via the Integrative Epidemiology Unit (MC_UU_12013/5). HRE, KB, JLM, CLR, DAL and GDS work in the Medical Research Council Integrative Epidemiology Unit at the University of Bristol, which is supported by the Medical Research Council and the University of Bristol (MC_UU_00011/5, MC_UU_00011/6 and MC_UU_00011/1). DAL is supported by a British Heart Foundation Chair (CH/F/20/90003) and National Institute for Health Research Senior Investigator award (NF-0616-10102). NC and AH received support from a Biomedical Research Centre Award to Imperial NHS Healthcare Trust. The funders played no role in the study design and conduct, or in these analyses or the decision to submit the manuscript for publication. The SABRE study group is entirely independent from the funding bodies.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The SABRE study was approved by St Mary's Hospital Research Ethics Committee (07/H0712/109) and all participants provided written informed consent. BiB study ethical approval for the data collection was granted by Bradford Research Ethics Committee (Ref 07/H1302/112).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Author email addresses:
Kimberley Burrows, kimberley.burrows{at}bristol.ac.uk
Josine L. Min, josine.min{at}bristol.ac.uk
Therese Tillin, t.tillin{at}ucl.ac.uk
Dan Mason Dan.Mason{at}bthft.nhs.uk
John Wright, John.wright{at}bthft.nhs.uk
Gillian Santorelli, Gillian.Santorelli{at}bthft.nhs.uk
George Davey Smith, kz.davey-smith{at}bristol.ac.uk
Deborah A. Lawlor, d.a.lawlor{at}bristol.ac.uk
Alun D. Hughes, alun.hughes{at}ucl.ac.uk
Nish Chaturvedi, n.chaturvedi{at}ucl.ac.uk
Caroline L. Relton, caroline.relton{at}bristol.ac.uk
Data Availability
SABRE data used for this submission will be made available on request to mrclha.swiftinfo@ucl.ac.uk. Further details regarding data sharing can be found on the cohort webpages (https://www.sabrestudy.org/home-2/data-sharing/). Born in Bradford data used for this submission will be made available on request to the Born in Bradford executive committee (borninbradford@bthft.nhs.uk). The Born in Bradford data management plan (available here: https://borninbradford.nhs.uk/research/how-to-access-data/) describes in detail the policy regarding data sharing, which is through a system of managed open access.